Publication
Outcomes Following OnabotulinumtoxinA Injection for Storage Symptoms in Patients Who Have Been Treated for Prostate Cancer.
Allison G Booher, Amy L Tin, Brittney L Murray, Nicole Liso, Feliz Cheung, Jaspreet S Sandhu, Divya Ajay
Neurourology and urodynamicsSep 8, 2026PMID 42711961doi:10.1002/nau.70431 Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 10, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260910-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
PURPOSE: Treatment of prostate cancer (PC) can cause storage symptoms, for which bladder onabotulinumtoxinA (BTXA) is a treatment option. We hypothesized that BTXA is effective and safe in patients treated for PC, regardless of treatment modality, with more favorable outcomes among patients treated…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Prostate Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.